⌘K
Loading ticker…
Roivant Sciences Ltd. Common Shares · Healthcare · Pharmaceutical Products
As of 2026-06-26, Roivant Sciences Ltd. Common Shares (ROIV) has a 3-month relative strength percentile of 76 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 76. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.5%, relative volume 2.11×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 76, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ROIV is in a stage 2 uptrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 15.3% / 41.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
ROIV is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.02% weight, $410M notional. Top 3 carry $873M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.02% | $410M |
| VBVanguard Small Cap ETF | 0.18% | $297M |
| VBKVanguard Small-Cap Growth ETF | 0.43% | $166M |
| VXFVanguard Extended Market ETF | 0.17% | $139M |
| IWDiShares Russell 1000 Value ETF | 0.04% | $27M |
| IWBiShares Russell 1000 ETF | 0.02% | $8M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ROIV Jan avg: -3.34% median: -3.14% win: 25% σ: 6.47% n: 4 2022-04-12 → 2026-05-29 | ROIV Feb avg: 10.56% median: 5.93% win: 50% σ: 17.57% n: 4 2022-04-12 → 2026-05-29 | ROIV Mar avg: -6.74% median: -6.96% win: 0% σ: 1.99% n: 4 2022-04-12 → 2026-05-29 | ROIV Apr avg: 5.57% median: 3.42% win: 80% σ: 10.46% n: 5 2022-04-12 → 2026-05-29 | ROIV May avg: 4.28% median: 5.12% win: 60% σ: 10.51% n: 5 2022-04-12 → 2026-05-29 | ROIV Jun avg: 1.78% median: 2.29% win: 75% σ: 7.87% n: 4 2022-04-12 → 2026-05-29 (current) | ROIV Jul avg: 5.02% median: 1.72% win: 75% σ: 9.43% n: 4 2022-04-12 → 2026-05-29 | ROIV Aug avg: 0.94% median: 0.80% win: 50% σ: 10.11% n: 4 2022-04-12 → 2026-05-29 | ROIV Sep avg: 3.15% median: -2.35% win: 50% σ: 16.37% n: 4 2022-04-12 → 2026-05-29 | ROIV Oct avg: 16.45% median: 16.10% win: 75% σ: 37.34% n: 4 2022-04-12 → 2026-05-29 | ROIV Nov avg: 7.27% median: 7.16% win: 100% σ: 3.56% n: 4 2022-04-12 → 2026-05-29 | ROIV Dec avg: 15.97% median: 10.87% win: 75% σ: 24.21% n: 4 2022-04-12 → 2026-05-29 |